Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients.

A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)